Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities (Details Narrative)

v3.24.1.u1
Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]        
Restricted cash $ 250 $ 250 $ 250 $ 250
Unrealized gain on securities available-for-sale 87 $ 229    
Accumulated unrealized losses $ 134   $ 221